Protagenic Therapeutics, Inc.\new (PTIX) Research & Development (2013 - 2026)
Protagenic Therapeutics, Inc.\new's Research & Development came in at $109,925 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 72.1% from $394,112 a year earlier but up 36.1% from the prior quarter.
Protagenic Therapeutics, Inc.\new (PTIX) Research & Development (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Protagenic Therapeutics, Inc.\new reported Research & Development of $617,709, down 56.7% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $901,896, up 139.4% from FY2025.
- Research & Development carries a five-year compound annual growth rate of -4.5% (FY2021 to FY2026).
- Going back by fiscal year, Research & Development was $376,740 in FY2025, $3.84 million in FY2024 (+25.5%), $3.06 million in FY2023 (+92.8%) and $1.59 million in FY2022 (+39.8%).
- The five-year range for quarterly Research & Development is $80,769 (fiscal Q4 2026) to $880,372 (fiscal Q4 2025).
- Business Quant data shows PTIX's Research & Development at $80,769 (Q4 2026), $153,786 (Q3 2026) and $273,229 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.48 Bn | 1,132.06 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 631.16 Bn | 549.69 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 502.63 Bn | 475.74 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 378.53 Bn | 332.91 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 302.83 Bn | 266.82 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 265.92 Bn | 239.60 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 240.87 Bn | 196.27 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.04 Bn | 168.24 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.38 Mn | 1.38 Mn | - | 109,925.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 109,925.00 |
| Mar 31, 2026 | 80,769.00 |
| Dec 31, 2025 | 153,786.00 |
| Sep 30, 2025 | 273,229.00 |
| Jun 30, 2025 | 394,112.00 |
| Mar 31, 2025 | 880,372.00 |
| Dec 31, 2024 | 134,580.00 |
| Sep 30, 2024 | 16,964.00 |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 671,169.00 |
| Mar 31, 2023 | 348,031.00 |
| Dec 31, 2022 | 257,520.00 |
| Sep 30, 2022 | 501,366.00 |
| Jun 30, 2022 | 160,515.00 |
| Mar 31, 2022 | 669,838.00 |
| Dec 31, 2021 | 146,568.00 |
| Sep 30, 2021 | 257,279.00 |
Protagenic Therapeutics, Inc.\new Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();